A transgenic zebrafish model of hepatocyte function in human Z α1-antitrypsin deficiency

被引:2
|
作者
Yip, Evelyn [1 ]
Giousoh, Aminah [1 ]
Fung, Connie [1 ]
Wilding, Brendan [1 ]
Prakash, Monica D. [1 ]
Williams, Caitlin [2 ]
Verkade, Heather [3 ]
Bryson-Richardson, Robert J. [2 ]
Bird, Phillip I. [1 ]
机构
[1] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia
[2] Monash Univ, Sch Biol Sci, Melbourne, Vic 3800, Australia
[3] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia
基金
英国医学研究理事会;
关键词
alpha(1)-antitrypsin deficiency; Danio rerio; liver; serpin; SERPINA1; LIVER-DISEASE; MOUSE MODEL; ALPHA(1)-ANTITRYPSIN DEFICIENCY; GENE-EXPRESSION; ACCUMULATION; TRANSPOSON; HEPATITIS; MECHANISM; PATHOLOGY; CIRRHOSIS;
D O I
10.1515/hsz-2018-0391
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In human alpha 1-antitrypsin deficiency, homozygous carriers of the Z (E324K) mutation in the gene SERPINA1 have insufficient circulating alpha 1-antitrypsin and are predisposed to emphysema. Misfolding and accumulation of the mutant protein in hepatocytes also causes endoplasmic reticulum stress and underpins long-term liver damage. Here, we describe transgenic zebrafish (Danio rerio) expressing the wildtype or the Z mutant form of human alpha 1-antitrypsin in hepatocytes. As observed in afflicted humans, and in rodent models, about 80% less alpha 1-antitrypsin is evident in the circulation of zebrafish expressing the Z mutant. Although these zebrafish also show signs of liver stress, they do not accumulate alpha 1-antitrypsin in hepatocytes. This new zebrafish model will provide useful insights into understanding and treatment of alpha 1-antitrypsin deficiency.
引用
收藏
页码:1603 / 1616
页数:14
相关论文
共 50 条
  • [31] Occupational exposure risks in individuals with PI*Z α1-antitrypsin deficiency
    Mayer, AS
    Stoller, JK
    Bartelson, BB
    Ruttenber, AJ
    Sandhaus, RA
    Newman, LS
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (02) : 553 - 558
  • [32] hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency
    Segeritz, Charis-Patricia
    Rashid, Sheikh Tamir
    de Brito, Miguel Cardoso
    Serra, Maria Paola
    Ordonez, Adriana
    Morell, Carola Maria
    Kaserman, Joseph E.
    Madrigal, Pedro
    Hannan, Nicholas R. F.
    Gatto, Laurent
    Tan, Lu
    Wilson, Andrew A.
    Lilley, Kathryn
    Marciniak, Stefan J.
    Gooptu, Bibek
    Lomas, David A.
    Vallier, Ludovic
    JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 851 - 860
  • [33] Rate of progression of lung function impairment in α1-antitrypsin deficiency
    Dawkins, P. A.
    Dawkins, C. L.
    Wood, A. M.
    Nightingale, P. G.
    Stockley, J. A.
    Stockley, R. A.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (06) : 1338 - 1344
  • [34] α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency
    Bazzan, Erica
    Tine, Mariaenrica
    Biondini, Davide
    Benetti, Riccardo
    Baraldo, Simonetta
    Turato, Graziella
    Fagiuoli, Stefano
    Sonzogni, Aurelio
    Rigobello, Chiara
    Rea, Federico
    Calabrese, Fiorella
    Foschino-Barbaro, Maria Pia
    Miranda, Elena
    Lomas, David A.
    Saetta, Marina
    Cosio, Manuel G.
    CHEST, 2018, 154 (03) : 607 - 616
  • [35] Compelling evidence for the efficacy of α1-antitrypsin augmentation treatment for α1-antitrypsin deficiency
    Crystal, Ronald G.
    LANCET RESPIRATORY MEDICINE, 2017, 5 (01): : 7 - 8
  • [36] Intrapleural Administration of an AAVrh.10 Vector Coding for Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency
    Chiuchiolo, Maria J.
    Kaminsky, Stephen M.
    Sondhi, Dolan
    Hackett, Neil R.
    Rosenberg, Jonathan B.
    Frenk, Esther Z.
    Hwang, Yihharn
    Van de Graaf, Benjamin G.
    Hutt, Julie A.
    Wang, Gensheng
    Benson, Janet
    Crystal, Ronald G.
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2013, 24 (04) : 161 - 173
  • [37] Long-term treatment of α1-antitrypsin deficiency-related pulmonary emphysema with human α1-antitrypsin
    Wencker, M
    Banik, N
    Buhl, R
    Seidel, R
    Konietzko, N
    EUROPEAN RESPIRATORY JOURNAL, 1998, 11 (02) : 428 - 433
  • [38] Towards targeted treatment for α1-antitrypsin deficiency:: Rationally selected small molecules abolish the polymerisation of Z α1-antitrypsin in vitro and in a liver cell model of disease
    Mallya, M.
    Gooptu, B.
    Phillips, R. L.
    Saldanha, A.
    Brown, S. C. Leigh
    Termine, D.
    Shirvani, A.
    Wu, Y.
    Barrett, T. E.
    Sifers, R.
    Abagyan, R.
    Lomas, D. A.
    THORAX, 2007, 62 : A1 - A2
  • [39] α1-Antitrypsin deficiency: A pediatric perspective
    Schwerk N.
    Kardorff R.
    Der Pneumologe, 2010, 7 (5): : 365 - 369
  • [40] Successful α1-antitrypsin replacement therapy in a patient with α1-antitrypsin deficiency and granulomatosis with polyangiitis
    Hernandez Perez, Jose Maria
    Garcia, Sergio Fumero
    Pio, Alberto Alvarez
    RHEUMATOLOGY, 2013, 52 (04) : 755 - 757